$INKT
MiNK Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New York, NY
INKT chart
What traders are saying about $INKT
Latest postsMiNK Therapeutics, Inc. news
- (INKT) Price Dynamics and Execution-Aware Positioning
Stock Traders Daily ·
- Jennifer S. Buell: Calling for Immediate Action to Expand Access to Promising Cancer Treatments
Oncodaily ·
- MiNK Therapeutics, Inc. Estimates – NASDAQ:INKT
TradingView ·
- Acute Respiratory Distress Syndrome Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
StreetInsider ·
- B. Riley Securities reiterates Buy rating on MiNK Therapeutics, $50 price target
TradingView ·
- B. Riley Securities Maintains MiNK Therapeutics(INKT.US) With Buy Rating, Raises Target Price to $50
Moomoo ·
- MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026
Yahoo Finance ·
- MiNK Therapeutics Selected for ARPA-H-Funded Initiative to Advance Room-Temperature Cell Therapy
Yahoo Finance ·
- MiNK Therapeutics (INKT) Q2 2026 Earnings Call Transcript
fool.com ·
- MiNK Therapeutics, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- MiNK Therapeutics Inc (INKT) (Q2 2026) Earnings Call Highlights: AGENT-797 Shows Early Promise ...
Yahoo Finance ·
- MiNK Therapeutics Q2 Earnings Call Highlights
marketbeat.com ·
MiNK Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$12.5M | -$10.8M | -$22.5M | -$28.0M |
| Diluted EPS | $-2.93 | $-2.86 | $-6.54 | $-0.83 |
| Total assets (year end) | $14.2M | $5.7M | $4.6M | $21.5M |
| Cash and equivalents (year end) | $13.4M | $4.6M | $3.4M | $19.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About MiNK Therapeutics, Inc.
- Ticker
- INKT (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1840229
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
Frequently asked questions
What exchange is MiNK Therapeutics, Inc. listed on?
MiNK Therapeutics, Inc. trades on the Nasdaq under the ticker symbol INKT.
What industry is MiNK Therapeutics, Inc. in?
MiNK Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is MiNK Therapeutics, Inc. headquartered?
MiNK Therapeutics, Inc.'s business address on file with the SEC is in New York, NY.
When does MiNK Therapeutics, Inc.'s fiscal year end?
MiNK Therapeutics, Inc.'s fiscal year ends on December 31.